Essential Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.16K Buy
343
+2
+0.6% +$18 ﹤0.01% 1735
2026
Q2
$2.38K Buy
341
+243
+248% +$1.35K ﹤0.01% 1906
2026
Q1
$383 Buy
98
+79
+416% +$351 ﹤0.01% 2507
2025
Q4
$86 Sell
19
-69
-78% -$354 ﹤0.01% 2573
2025
Q3
$539 Sell
88
-13
-13% -$82 ﹤0.01% 2187
2025
Q2
$654 Buy
+101
New +$544 ﹤0.01% 1626

Other funds holding TBI

Essential Partners's TBI Position: Q3 2026 in Review

Essential Partners increased its Trueblue (TBI) stake by 0.59% in Q3 2026, buying an estimated $18 and bringing the position to 343 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Essential Partners first reported a position in TBI in Q2 2025 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold TBI as of Q3 2026.

  • Essential Partners held 343 shares of Trueblue worth $3.16K as of Q3 2026.
  • Essential Partners bought 2 Trueblue shares in Q3 2026, an estimated $18.
  • Trueblue made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1735 holding.
  • Essential Partners first reported a position in Trueblue in Q2 2025 and has held it in 6 quarters since.
  • 10 funds tracked by Wall St. Rank held Trueblue as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.